PROSPECT CRYPTOSPORIDIUM RAPID ASSAY— 510(k) K936191

Substantially Equivalent

Alexon Biomedical, Inc.

FDA 510(k) clearance K936191 for PROSPECT CRYPTOSPORIDIUM RAPID ASSAY, Substantially Equivalent on 1994-11-17. Applicant: Alexon Biomedical, Inc..

Clearance details

Applicant: Alexon Biomedical, Inc.
Product code: Code MHJ
Advisory panel: Microbiology
Date received: 1993-12-23
Decision date: 1994-11-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.